4Paiicer MJ, Deshpande C,Rankin J,et al. 2011. Type 1 col-lagenopathy presenting with a ussell - Silver phenotype. AmericanJournal of Medical Genetics Part A, 155A(6) :1414 - 1418.
5Malfait F, Symoens S, De Backer J, et al. 2007. Three aiinine tocysteine substitutions in the pro - alpha (D - collagen chain causeEhlere - Danlos syndrome with a propensity to arterial rupture in earlyadulthood. Humam Mutation,28(4) :387 -395.
3Zhang XH, Guan T, Man J, et al. Disparity and its time trends in stroke morlality between urban and rural populations in China 1987 to 2001 : changing patterns and their implications for publie health policy [J]. Stroke, 2007, 38(12) : 3139 -3144.
5Dalgleish R. The human type Ⅰ collagen mutation database [ J ].Nucleic Acids Res, 1997, 25( 1 ) : 181 - 187.
6Zhu Y, Li W, Ge M, et al. Polymorphism rs42524 of COL1A2 and sporadic intracranial aneurysms in the Chinese population [ J ]. J Neurosurg, 2008, 109(6): 1060-1064.
7Zhang B, Fugleholm K, Day LB, et al. Molecular pathogenesis of subarachnoid haemorrhage [ J ]. Int J Biochem Cell Biol, 2003, 35 (9) : 1341 - 1360.
8Ruigrok YM, Rinkel GJ, Wijmenga C. Genetics of intracranial aneurysms [J]. Lancet Neurol, 2005, 4(3): 179- 189.
9Gajko-Galicka A. Mutations in type Ⅰ collagen genes resulting in osteogenesis imperfecta in humans [ J]. Acta Biochim Pol, 2002, 49 (2) : 433 -441.
10Yoneyama T, Kasuya H, Onda H, et al. Collagen type Ⅰ alpha2 (COL1A2) is the susceptible gene for intracranial aneurysms [ J ]. Stroke, 2004, 35 (2) : 443 - 448.
